Research ArticleArticle

Declines in Erythrocyte Sedimentation Rates in Patients with Rheumatoid Arthritis Over the Second Half of the 20th Century

BENJAMIN ABELSON, TUULIKKI SOKKA and THEODORE PINCUS
The Journal of Rheumatology August 2009, 36 (8) 1596-1599; DOI: https://doi.org/10.3899/jrheum.081255

REFERENCES

  1. 1.↵
    1. Fauci AS,
    2. Langford CA
    1. Lipsky PE
    . Rheumatoid arthritis. In: Fauci AS, Langford CA, editors. Harrison’s rheumatology. New York: McGraw-Hill; 2006:85–104.
  2. 2.↵
    1. Koopman WJ,
    2. Moreland LW
    1. Chatham WW,
    2. Blackburn WD, Jr
    . Laboratory findings in rheumatoid arthritis. In: Koopman WJ, Moreland LW, editors. Arthritis and allied conditions: a textbook of rheumatology. 15th ed. Philadelphia: Lippincott, Williams & Wilkins; 2005:1207–21.
  3. 3.↵
    1. Wolfe F,
    2. Michaud K
    . The clinical and research significance of the erythrocyte sedimentation rate. J Rheumatol 1994;21:1227–37.
    OpenUrlPubMed
  4. 4.
    1. Sokka T,
    2. Pincus T
    . Erythrocyte sedimentation rate, C-reactive protein, or rheumatoid factor are normal at presentation in 35%–45% of patients with rheumatoid arthritis seen between 1980 and 2004: Analyses from Finland and the United States. J Rheumatol 2009;36:1387–90.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Pincus T,
    2. Sokka T,
    3. Kautiainen H
    . Patients seen for standard rheumatoid arthritis care have significantly better articular, radiographic, laboratory, and functional status in 2000 than in 1985. Arthritis Rheum 2005;52:1009–19.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Sokka T,
    2. Abelson B,
    3. Pincus T
    . Mortality in rheumatoid arthritis: 2008 update. Clin Exp Rheumatol 2008;26:S35–S61.
    OpenUrlPubMed
  7. 7.↵
    1. Vandenbroucke JP,
    2. Hazevoert HM,
    3. Cats A
    . Survival and cause of death in rheumatoid arthritis: A 25-year prospective followup. J Rheumatol 1984;11:158–61.
    OpenUrlPubMed
  8. 8.↵
    1. Wolfe F,
    2. Mitchell DM,
    3. Sibley JT,
    4. et al.
    The mortality of rheumatoid arthritis. Arthritis Rheum 1994;37:481–94.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Kremers HM,
    2. Nicola PJ,
    3. Crowson CS,
    4. Ballman KV,
    5. Gabriel SE
    . Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum 2005;52:722–32.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Jacoby RK,
    2. Jayson MIV,
    3. Cosh JA
    . Onset, early stages, and prognosis of rheumatoid arthritis: a clinical study of 100 patients with 11-year follow-up. Br Med J 1973;2:96–100.
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    1. Gordon DA,
    2. Stein JL,
    3. Broder I
    . The extra-articular features of rheumatoid arthritis: a systematic analysis of 127 cases. Am J Med 1973;54:445–52.
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Book C,
    2. Saxne T,
    3. Jacobsson LTH
    . Prediction of mortality in rheumatoid arthritis based on disease activity markers. J Rheumatol 2005;32:430–4.
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    1. Krause D,
    2. Schleusser B,
    3. Herborn G,
    4. Rau R
    . Response to methotrexate treatment is associated with reduced mortality in patients with severe rheumatoid arthritis. Arthritis Rheum 2000;43:14–21.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Wolfe F,
    2. Kleinheksel SM,
    3. Cathey MA,
    4. Hawley DJ,
    5. Spitz PW,
    6. Fries JF
    . The clinical value of the Stanford Health Assessment Questionnaire Functional Disability Index in patients with rheumatoid arthritis. J Rheumatol 1988;15:1480–8.
    OpenUrlPubMed
  15. 15.↵
    1. Chehata JC,
    2. Hassell AB,
    3. Clarke SA,
    4. et al.
    Mortality in rheumatoid arthritis: relationship to single and composite measures of disease activity. Rheumatology 2001;40:447–52.
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    1. Choi HK,
    2. Hernán MA,
    3. Seeger JD,
    4. Robins JM,
    5. Wolfe F
    . Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet 2002;359:1173–7.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Wolfe F,
    2. Michaud K,
    3. Gefeller O,
    4. Choi HK
    . Predicting mortality in patients with rheumatoid arthritis. Arthritis Rheum 2003;48:1530–42.
    OpenUrlCrossRefPubMed
  18. 18.↵
    1. Kremer JM
    . Safety, efficacy, and mortality in a long-term cohort of patients with rheumatoid arthritis taking methotrexate: Followup after a mean of 13.3 years. Arthritis Rheum 1997;40:984–5.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Sokka T,
    2. Möttönen T,
    3. Hannonen P
    . Mortality in early “sawtooth” treated rheumatoid arthritis patients during the first 8–14 years. Scand J Rheumatol 1999;28:282–7.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. Maiden N,
    2. Capell HA,
    3. Madhok R,
    4. Hampson R,
    5. Thomson EA
    . Does social disadvantage contribute to the excess mortality in rheumatoid arthritis patients? Ann Rheum Dis 1999;58:525–9.
    OpenUrlAbstract/FREE Full Text
  21. 21.↵
    1. Callahan LF,
    2. Pincus T,
    3. Huston JW, III,
    4. Brooks RH,
    5. Nance EP, Jr,
    6. Kaye JJ
    . Measures of activity and damage in rheumatoid arthritis: Depiction of changes and prediction of mortality over five years. Arthritis Care Res 1997;10:381–94.
    OpenUrlPubMed
  22. 22.↵
    1. Lindqvist E,
    2. Eberhardt K
    . Mortality in rheumatoid arthritis patients with disease onset in the 1980s. Ann Rheum Dis 1999;58:11–4.
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    1. Kroot EJ,
    2. van Leeuwen MA,
    3. van Rijswijk MH,
    4. et al.
    No increased mortality in patients with rheumatoid arthritis: up to 10 years of follow up from disease onset. Ann Rheum Dis 2000;59:954–8.
    OpenUrlAbstract/FREE Full Text
  24. 24.↵
    1. Peltomaa R,
    2. Paimela L,
    3. Kautiainen H,
    4. Leirisalo-Repo M
    . Mortality in patients with rheumatoid arthritis treated actively from the time of diagnosis. Ann Rheum Dis 2002;61:889–94.
    OpenUrlAbstract/FREE Full Text
  25. 25.↵
    1. Soderlin MK,
    2. Nieminen P,
    3. Hakala M
    . Functional status predicts mortality in a community based rheumatoid arthritis population. J Rheumatol 1998;25:1895–9.
    OpenUrlPubMed
  26. 26.↵
    1. Mattey DL,
    2. Thomson W,
    3. Ollier WE,
    4. et al.
    Association of DRB1 shared epitope genotypes with early mortality in rheumatoid arthritis: results of eighteen years of followup from the early rheumatoid arthritis study. Arthritis Rheum 2007;56:1408–16.
    OpenUrlCrossRefPubMed
  27. 27.↵
    1. Nikolaisen C,
    2. Figenschau Y,
    3. Nossent JC
    . Anemia in early rheumatoid arthritis is associated with interleukin 6-mediated bone marrow suppression, but has no effect on disease course or mortality. J Rheumatol 2008;35:380–6.
    OpenUrlAbstract/FREE Full Text
  28. 28.↵
    1. Gonzalez-Gay MA,
    2. Gonzalez-Juanatey C,
    3. Lopez-Diaz MJ,
    4. et al.
    HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis. Arthritis Rheum 2007;57:125–32.
    OpenUrlCrossRefPubMed
  29. 29.↵
    1. Escalante A,
    2. Haas RW,
    3. Del Rincón I
    . Paradoxical effect of body mass index on survival in rheumatoid arthritis: role of comorbidity and systemic inflammation. Arch Intern Med 2005;165:1624–9.
    OpenUrlCrossRefPubMed
  30. 30.↵
    1. Silman A,
    2. Davies P,
    3. Currey HLF,
    4. Evans SJW
    . Is rheumatoid arthritis becoming less severe? J Chronic Dis 1983;36:891–7.
    OpenUrlCrossRefPubMed
  31. 31.↵
    1. Uhlig T,
    2. Kvien TK
    . Has rheumatoid arthritis become a milder disease? Drug Discovery Today 2005;2:331–6.
    OpenUrlCrossRef
  32. 32.↵
    1. Nishimura K,
    2. Sugiyama D,
    3. Kogata Y,
    4. et al.
    Meta-analysis: Diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Intern Med 2007;146:797–808.
    OpenUrlCrossRefPubMed
  33. 33.↵
    1. Sokka T,
    2. Kautiainen H,
    3. Toloza S,
    4. et al.
    QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries. Ann Rheum Dis 2007;66:1491–6.
    OpenUrlAbstract/FREE Full Text
  34. 34.↵
    1. Sokka T,
    2. Pincus T
    . Most patients receiving routine care for rheumatoid arthritis in 2001 did not meet inclusion criteria for most recent clinical trials or American College of Rheumatology criteria for remission. J Rheumatol 2003;30:1138–46.
    OpenUrlAbstract/FREE Full Text
  35. 35.↵
    1. Sokka T,
    2. Hetland ML,
    3. Makinen H,
    4. et al.
    Remission and rheumatoid arthritis: Data on patients receiving usual care in twenty-four countries. Arthritis Rheum 2008;58:2642–51.
    OpenUrlCrossRefPubMed
  36. 36.↵
    1. Lijmer JG,
    2. Mol BW,
    3. Heisterkamp S,
    4. et al.
    Empirical evidence of design-related bias in studies of diagnostic tests. JAMA 1999;282:1061–6.
    OpenUrlCrossRefPubMed
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

 Request Permissions

Bookmark this article

Jump to section